CD8A and neoplasm: Injection of OT-I CD8+ T cells was performed 24 hours after α-RIT to benefit from the early effects of ionizing radiation on the tumor (e.g inflammatory context, release of cytokines and/or DAMPs...) without any damage to the transferred T cells because bismuth half-life is very short.